This inventor holds 1 USPTO granted patent. Top assignee: Inje University Industry-Academic Cooperation Foundation. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Seong Han Kim: Advancing Research on Corneal Neovascularization
Introduction
Seong Han Kim is an inventor associated with Busan, South Korea, and the Inje University Industry-Academic Cooperation Foundation. His work includes a cell-model approach for studying diseases associated with corneal neovascularization.
Latest Patents
Kim is associated with 1 patent, titled “Cell Model for Neovascular Diseases Using EBV-Infected Human Corneal Epithelial Cells.” The invention describes preparing a disease model by infecting human corneal epithelial cells (HCECs) with Epstein–Barr virus (EBV), culturing the infected cells, and determining whether infection has occurred. The model is also proposed as a tool for screening diseases associated with corneal neovascularization.
Career Highlights
The patent focuses on developing a laboratory cell model that may support research into corneal neovascular diseases. By using EBV-infected HCECs, the disclosed method provides a defined process for preparing cells for disease-related study and screening.
Collaborations
The patent lists Ga Bin Park and Dae Jin Kim among Kim’s collaborators. The work is associated with the Inje University Industry-Academic Cooperation Foundation.
Conclusion
Seong Han Kim’s patent describes an EBV-infected corneal epithelial cell model intended to support research and screening related to corneal neovascularization.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile